EC Number |
BRENDA No. |
Title |
Journal |
Volume |
Pages |
Year |
Organism |
PubMed ID |
---|
1.3.1.118 | 748167 |
A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis |
J. Biol. Chem. |
285 |
14330-14337 |
2010 |
Mycobacterium tuberculosis |
20200152 |
1.3.1.118 | 748167 |
A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis |
J. Biol. Chem. |
285 |
14330-14337 |
2010 |
Mycobacterium tuberculosis ATCC 25618 |
20200152 |
1.3.1.118 | 747697 |
An overview on crystal structures of InhA protein Apo-form, in complex with its natural ligands and inhibitors |
Eur. J. Med. Chem. |
146 |
318-343 |
2018 |
Mycobacterium tuberculosis |
29407960 |
1.3.1.118 | 747697 |
An overview on crystal structures of InhA protein Apo-form, in complex with its natural ligands and inhibitors |
Eur. J. Med. Chem. |
146 |
318-343 |
2018 |
Mycobacterium tuberculosis ATCC 25618 |
29407960 |
1.3.1.118 | 748433 |
Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex A molecular dynamics simulation study |
J. Mol. Model. |
18 |
1779-1790 |
2012 |
Mycobacterium tuberculosis |
21833828 |
1.3.1.118 | 748433 |
Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex A molecular dynamics simulation study |
J. Mol. Model. |
18 |
1779-1790 |
2012 |
Mycobacterium tuberculosis ATCC 25618 |
21833828 |
1.3.1.118 | 748146 |
Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate |
J. Biol. Chem. |
274 |
15582-15598 |
1999 |
Mycobacterium tuberculosis |
10336454 |
1.3.1.118 | 748146 |
Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate |
J. Biol. Chem. |
274 |
15582-15598 |
1999 |
Mycobacterium tuberculosis ATCC 25618 |
10336454 |
1.3.1.118 | 747700 |
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis |
Eur. J. Med. Chem. |
86 |
613-627 |
2014 |
Mycobacterium tuberculosis |
25218910 |
1.3.1.118 | 747700 |
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis |
Eur. J. Med. Chem. |
86 |
613-627 |
2014 |
Mycobacterium tuberculosis ATCC 25618 |
25218910 |